InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

INTENSITY THERAPEUTICS, INC.

INTS Clue Score37
United States Fiscal year ends December CIK 0001567264
$3.63 -1.36% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.63 −14.79% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 30 Jun 2023. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2022Operating income−7.6Net income−7.6EPS, diluted−2.22Fiscal year 2023Operating income−8.3Net income−10.5EPS, diluted−1.38Fiscal year 2024Operating income−16.6Net income−16.3EPS, diluted−29.24Fiscal year 2025Operating income−12.0Net income−11.6EPS, diluted−8.56
FY2022FY2023FY2024FY2025
Operating income −7.6 −8.3 −16.6 −12.0
Net income −7.6 −10.5 −16.3 −11.6
Growth
EPS, diluted −2.22 −1.38 −29.24 −8.56

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2022Operating cash flow−5.5Fiscal year 2023Operating cash flow−7.2Fiscal year 2024Operating cash flow−15.2Fiscal year 2025Operating cash flow−9.2
FY2022FY2023FY2024FY2025
Operating cash flow −5.5 −7.2 −15.2 −9.2

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2022Cash1.3Shareholders’ equity−15.1Fiscal year 2023Cash8.6Shareholders’ equity13.2Fiscal year 2024Cash2.6Shareholders’ equity2.9Fiscal year 2025Cash11.9Shareholders’ equity11.9
FY2022FY2023FY2024FY2025
Cash 1.3 8.6 2.6 11.9
Shareholders’ equity −15.1 13.2 2.9 11.9

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Returns
n/a −80.1% −557.5% −97.7%
−431.5% −60.9% −340.1% −82.3%
Balance and payout
390.2% 23.9% 39.0% 15.8%